[1] 许小兵, 杨妙芳, 朱人敏. 生长抑素治疗肝纤维化研究进展[J]. 中国临床药理学与治疗学, 2009, 14(6): 707-710. [2] Ueno L, Sam M, Sakata R, et al. Hepatic stellate cells and intralobular innervation in human liver cirrhosis[J]. Hum Pathol, 1997, 28(8): 953-959. [3] Mancia G, Bousquet P, Elghozi JZ, et al. The sympathetic nervous system and the metabolic syndrome[J]. J Hypertens, 2007, 25(5): 909-920. [4] 陈猛, 马勇, 魏伟, 等. 去甲肾上腺素和酚妥拉明对大鼠肝星状细胞的影响[J]. 中国新药杂志, 2009, 18(3): 257-261. [5] Friedman SL. Liver fibrosis-from bench to bedside[J]. J Hepatol, 2003, 38(Suppl 1): S38-S53. [6] Cassiman D, Denef C, Desmet VJ, et al. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors[J]. Hepatology, 2001, 33(1): 148-158. [7] Oben JA, Roskams L, Yang S, et al. Hepatic fibrogenesis requires sympathetic neurotransmitters[J]. Gut, 2004, 53(3): 438-445. [8] Elsharkawy AM, Oakley E, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis[J]. Apoptosis, 2005, 10(5): 927-939. [9] Hellerbrand C, Jobin C, Limuro Y, et al. Inhibition of NFkappa B in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB superrepressor[J]. Hepatology, 1998, 27(5): 1285-1295. [10] Lang A, Schoonhoven R, Tuvia S, et al. Nuclear factor kappa B in proliferation, activation, and apoptosis in rat hepatic stellate cells[J]. J Hepatol, 2000, 33(1): 49-58. [11] Saile B, Matthes N, El Armouche H, et al. The bcl, NFκB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the antiapoptotic effect of TGF-b or TNF-a on activated hepatic stellate cells[J]. Eur J Cell Biol, 2001, 80: 554-561. [12] Sonenshein GE. Rel/NF-kappa B transcription factors and the control of apoptosis[J]. Semin Cancer Biol, 1997, 8(2): 113-119. |